Trial Profile
A prospective, open, randomized and comparative trial of the efficacy of a fixed-dose losartan/hydrochlorothiazide (Preminent) versus high-dose amlodipine using home blood pressure monitoring in the treatment of hypertension: ALPHABET Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Aug 2013
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Losartan/hydrochlorothiazide (Primary) ; Losartan
- Indications Essential hypertension
- Focus Biomarker; Therapeutic Use
- Acronyms ALPHABET
- 06 Sep 2011 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record..
- 10 Sep 2009 New trial record